Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02711670 · ClinicalTrials.gov registry record · NA
Night Time Use of Thiazide Diuretics for Improved Reduction in Stone Risk in Stone Formers With Elevated Urine Calcium
A NA study of Kidney Stones, sponsored by VA New York Harbor Healthcare System.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT02711670: Completed NA study of Kidney Stones, sponsored by VA New York Harbor Healthcare System.
NCT02711670 is a NA study of Kidney Stones that has completed, run by VA New York Harbor Healthcare System. The registered enrollment target is 10 participants, below the 294-participant average among 15 other Kidney Stones trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02711670, a NA study of Kidney Stones, has completed, sponsored by VA New York Harbor Healthcare System.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
Thiazide diuretics will be more effective in lowering urine calcium excretion if taken at night as compared to the daytime. It will therefore be more effective in reducing kidney stone recurrence in nephrolithiasis patients with elevated urine calcium who are known to have increased risk of kidney stones at night time.
Conditions Studied
Interventions
- DRUG chlorthalidone
- DRUG Hydrochlorothiazide
Study Locations (1)
New York
- VA New York Harbor Healthcare System - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2014-02 |
| Est. Completion | 2017-06 |
| Phase | NA |
What the finished NCT02711670 record still lists
NCT02711670 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 294-participant average among 15 other Kidney Stones trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Kidney Stones appearing as the primary indexed condition, and to 2 interventions - of which chlorthalidone is the first listed.
NCT02711670 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT02711670 about?
NCT02711670 is a clinical study titled "Night Time Use of Thiazide Diuretics for Improved Reduction in Stone Risk in Stone Formers With Elevated Urine Calcium". Thiazide diuretics will be more effective in lowering urine calcium excretion if taken at night as compared to the daytime. It will therefore be more effective in reducing kidney stone recurrence in nephrolithiasis patients with elevated urine calcium who are known to have increased risk of kidney s...
What is the current status of trial NCT02711670?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2014-02. Estimated completion is 2017-06.
What conditions does trial NCT02711670 study?
This clinical trial studies the following conditions: Kidney Stones.
What interventions are being tested in trial NCT02711670?
The interventions under investigation include: chlorthalidone (DRUG), Hydrochlorothiazide (DRUG).
Who is sponsoring clinical trial NCT02711670?
This trial is sponsored by VA New York Harbor Healthcare System, which has 9 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02711670 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Kidney Stones
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02711670's enrollment target sits among peer trials
10 15th of 15 the lowest of 15 other Kidney Stones trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Kidney Stones trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Endogenous Oxalate Synthesis in Idiopathic Calcium Oxalate Kidney Stone Disease
RECRUITING · NA
-
Evaluation of Eye Gaze Sharing in the Operating Room
RECRUITING · NA
-
Thulium Fiber Laser (TFL) vs Thulio Pulsed Thulium:YAG (p-Tm:YAG)
RECRUITING · NA
-
Eye Gaze Guidance Evaluation in Phantoms
RECRUITING · NA
-
Oxalate-Driven Host Responses in Kidney Stone Disease
RECRUITING · NA
-
Ultrasound Imaging of Kidney Stones and Lithotripsy
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia